M
Live / Applied — Fourth extension granted (statement of use) (as of 29 May 2025)
What this means for you
Not registered yet, but its 21 May 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90727555
- Mark type
- Design + words
- Filed
- 21 May 2021
- Published for opposition
- 04 Apr 2023
- Attorney of record
- Eric R. Moran
Goods and services
- Class 005 — Pharmaceuticals: House mark for a full line of pharmaceutical preparations; pharmaceutical preparations for reversal of effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery; pharmaceutical preparations, namely, demethylation agents; pharmaceutical preparations, namely, cholinesterase inhibitors for reversal of effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery
Owner
- Meitheal Pharmaceuticals, Inc., Chicago, IL, US
- Meitheal Pharmaceuticals, Inc., Chicago, IL, US
Prior registrations
Prosecution history
- 17 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 May 2025 — SOU EXTENSION 4 GRANTED
- 29 May 2025 — SOU EXTENSION 4 FILED
- 29 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Nov 2024 — SOU EXTENSION 3 GRANTED
- 22 Nov 2024 — SOU EXTENSION 3 FILED
- 22 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 29 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 May 2024 — SOU EXTENSION 2 GRANTED
- 28 May 2024 — SOU EXTENSION 2 FILED
- 28 May 2024 — SOU TEAS EXTENSION RECEIVED
- 01 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Nov 2023 — SOU EXTENSION 1 GRANTED